Physician profile
Anil K Chagarlamudi
NPI 1952308959
$26,845.83
in general payments reported to CMS, 2019-2025
35 companies · $7,479 in 2025
The $7,479 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,380 · 2020: $6,698 · 2021: $499 · 2022: $713 · 2023: $2,848 · 2024: $4,228 · 2025: $7,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,929 · Travel and Lodging: $5,026 · Long Term Medical Supply Or Device Loan: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,929.23 |
| Travel and Lodging | $5,025.77 |
| Long Term Medical Supply Or Device Loan | $1,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Venclose INC. | $10,120.67 | 2019-2020 | |
| Angiodynamics, INC. | $6,744.48 | 2020-2025 | Alphavac, Angiovac, Venacure 1470 Pro |
| Penumbra, INC. | $3,930.76 | 2024-2025 | Indigo System, Ruby Coil, Penumbra System |
| Abiomed | $1,023.71 | 2019-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $655.57 | 2020-2024 | Jardiance |
| Philips North America LLC | $646.46 | 2021-2025 | Labosys, (Br5) Peripheral Ivus, (Az7) Lasers |
| Boston Scientific Corporation | $515.39 | 2019-2025 | Varithena Administration Pack, Eluvia, Athletis |
| Medtronic Vascular, INC. | $315.36 | 2019-2020 | |
| Novo Nordisk INC | $284.24 | 2025 | Ozempic, Wegovy |
| Shockwave Medical, INC | $261.27 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $244.86 | 2021-2023 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $237.23 | 2020-2025 | Lifevest |
| Abbott Laboratories | $229.03 | 2022-2025 | Cardiomems, Triclip, Coroflow |
| Amgen INC. | $222.91 | 2020-2025 | Repatha |
| Cardiac Dimensions, INC. | $178.90 | 2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $144.64 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $143.17 | 2023-2024 | Lokelma, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $121.81 | 2022 | |
| Cordis US Corp. | $115.02 | 2022-2025 | Brite Tip Radianz |
| Ge Healthcare | $96.77 | 2024 | |
| Janssen Pharmaceuticals, INC | $88.64 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $86.29 | 2022-2025 | Verquvo |
| Cardiva Medical, INC. | $83.60 | 2024-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Silk Road Medical, INC. | $60.42 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| E.R. Squibb & Sons, L.L.C. | $55.63 | 2024-2025 | Eliquis, Camzyos |
| Terumo Medical Corporation | $40.14 | 2021-2022 | |
| Inari Medical, INC. | $36.75 | 2019-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Contego Medical, INC | $24.14 | 2025 | |
| Asahi Intecc USA, INC. | $23.05 | 2025 | Asahi Peripheral Vascular Wires |
| Endologix LLC | $20.99 | 2025 | Endocross Device, Torus Stent Graft System |
| Regeneron Healthcare Solutions, INC. | $20.62 | 2025 | Evkeeza |
| Stryker Corporation | $20.30 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biocompatibles, INC. | $18.70 | 2019 | |
| Pfizer INC. | $17.31 | 2024 | |
| Veryan Medical Incorporated | $17.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Chagarlamudi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.